AXL mediates cetuximab and radiation resistance through tyrosine 821 and the c-ABL kinase pathway in head and neck cancer

PURPOSE: Radiation and cetuximab are therapeutics used in management of head and neck squamous cell carcinoma (HNSCC). Despite clinical success with these modalities, development of both intrinsic and acquired resistance is an emerging problem in the management of this disease. The purpose of this s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: McDaniel, Nellie K, Iida, Mari, Nickel, Kwangok P, Longhurst, Colin A, Fischbach, Samantha R, Rodems, Tamara S, Kranjac, Carlene A, Bo, Amber Y, Luo, Qianyun, Gallagher, Meghan M, Welke, Noah B, Mitchell, Kaitlyn R, Schulz, Alison E, Eckers, Jaimee C, Hu, Rong, Salgia, Ravi, Hong, Seungpyo, Bruce, Justine Y, Kimple, Randall J, Wheeler, Deric L
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442604/
https://ncbi.nlm.nih.gov/pubmed/32439698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados